Services
Education
Emory University School of Law (J.D., 2003) Michigan State University (B.A., 1998, with honors)Admissions
- District of Columbia
- Virginia
- United States Court of Appeals for the Fifth Circuit
- United States District Court for the Eastern District of Virginia
Accolades
“Matthew Malinowski is the kind of litigator who’s very seasoned, knows the systems very well and knows how to be effective. He clearly has a killer instinct in litigation. Although, if we had to take a different approach, he was very flexible and amenable to our needs and wants as a company. He was super helpful.”
–Client
“Matthew Malinowski’s client service and general level of service, level of sophistication, commercial awareness, and vision are all very strong. He is an excellent, first-rate trial lawyer. He developed comprehensive case strategy and assembled a high quality team to execute that strategy. He is a very clear, persuasive and articulate speaker.”
–Client
“Matt is experienced beyond his years. He is a fierce trial attorney who is not afraid to handle significant cases in unfavorable jurisdictions.”
–Client
“He is an amazing litigator with a solid understanding of the goals and interests of clients.”
–Client
“Matthew Malinowski is a smart cookie. He is tenacious, clear speaking, persuasive and quick to get to the point. He is very good.”
–Third Party
- Best Lawyers in America, Mass Tort Litigation / Class Actions, 2024
- Super Lawyers, Business Litigation, 2023 and 2024
Memberships
- Defense Research Institute (DRI), Member, 2004 – Present
- The John Carroll Society, 2009 – Present
- National Association of Railroad Trial Counsel (NARTC), 2007 – Present
- Executive Committees on Preemption and Program Issues, Member
- Annual Trial College, Faculty Member Instructor
Insights & Events
Bloomberg Law: Agency Challengers Get a More Even Playing Field Post-Chevron
publication | July 2, 2024Firm Partners Robert Johnston and Matthew Malinowski Speak at NARTC’s 69th Annual Meeting
event | July 26, 2023Firm Client Lauded for Collaboration Conducting Trial Amid Pandemic in High-Profile Industrial Disaster
news | February 2, 2022Hollingsworth LLP Conducts In-Person Civil Jury Trial Amid COVID-19 Pandemic
news | December 28, 2020Robert Johnston and Matt Malinowski serve as faculty at the National Association of Railroad Trial Counsel (NARTC) trial advocacy college.
news | June 1, 2015Pursuing Sanctions Under 28 U.S.C. § 1927: An Underused Defense Strategy
publication | January 28, 2015By Matthew J. Malinowski for DRI's The Voice.
Avoiding the Sideshow: One Trial Judge’s Textbook Application of Daubert to Exclude Dubious Testimony
publication | June 3, 2011Washington Legal Foundation's Legal Backgrounder (June 3, 2011) (Matthew J. Malinowski)
State court grants motion to dismiss for forum non conveniens to Firm client C.R. Bard, Inc.
news | August 25, 2008Cases
The Zometa Cases
- Precedent
- Pharmaceutical & Medical Device
- Toxic Torts & Products Liability
- Class Action Defense
- January 27, 2015
Federal Court Grants Daubert and SJ Motions to General Motors in PCB Lawsuit
- Precedent
- Environmental
- Toxic Torts & Products Liability
- October 1, 2006
5th Circuit Affirms Novartis Summary Judgment in Tegretol Innovator Liability Case
- Case
- Pharmaceutical & Medical Device
- Toxic Torts & Products Liability
- February 5, 2021
Idaho Court Dismisses Innovator Liability Claims Against Novartis for Lack of Specific Personal Jurisdiction
- Case
- Pharmaceutical & Medical Device
- July 13, 2020
Firm Secures Voluntary Dismissal with Prejudice for Novartis
- Case
- Pharmaceutical & Medical Device
- Toxic Torts & Products Liability
- June 29, 2020
Idaho State Court Rejects Innovator Liability Claims Against Novartis
- Case
- Pharmaceutical & Medical Device
- Toxic Torts & Products Liability
- September 25, 2019
Novartis Gets Another Summary Judgment and Daubert Win Shortly Before Trial
- Case
- Pharmaceutical & Medical Device
- Toxic Torts & Products Liability
- July 2, 2014
Florida Court Dismisses Punitive Damages Claims in Aredia/Zometa Case
- Case
- Pharmaceutical & Medical Device
- Toxic Torts & Products Liability
- June 16, 2014
Arizona Federal Court Determines Novartis Warnings Adequate and Grants Summary Judgment
- Case
- Pharmaceutical & Medical Device
- Toxic Torts & Products Liability
- July 2, 2013
Novartis Scores Unanimous Defense Verdict from Florida Jury
- Case
- Pharmaceutical & Medical Device
- Toxic Torts & Products Liability
- April 9, 2013
Eastern District of New York Excludes Entire Testimony from Plaintiff”s Purported Regulatory and Warnings Expert
- Case
- Pharmaceutical & Medical Device
- May 3, 2011
NLJ Top Defense Win for Firm in First Trial of Hernia Repair Mesh Serial Litigation
- Case
- Pharmaceutical & Medical Device
- Toxic Torts & Products Liability
- June 10, 2004